CD274 and coronary artery disorder: As our understanding of the immunological landscape of the heart continues to evolve, it becomes increasingly clear that the PD-1/PD-L1 pathway is a key player in modulating both protective and pathological immune responses, with significant implications for the management of ischemic heart disease and other related conditions.